Presentation is loading. Please wait.

Presentation is loading. Please wait.

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester.

Similar presentations


Presentation on theme: "KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester."— Presentation transcript:

1 KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester H. Fox, MD, Tamara Isakova, MD, James P. Lash, MD, Carmen A. Peralta, MD, Manjula Kurella Tamura, MD, Harold I. Feldman, MD, MSCE  American Journal of Kidney Diseases  Volume 63, Issue 5, Pages (May 2014) DOI: /j.ajkd Copyright © Terms and Conditions

2 Green: low risk (if no other markers of kidney disease, no CKD); Yellow: moderately increased risk; Orange: high risk; Red, very high risk. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © Terms and Conditions


Download ppt "KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester."

Similar presentations


Ads by Google